nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylphenidate—SLC6A3—attention deficit hyperactivity disorder	0.512	0.572	CbGaD
Methylphenidate—SLC6A4—attention deficit hyperactivity disorder	0.383	0.428	CbGaD
Methylphenidate—SLC6A2—locus ceruleus—attention deficit hyperactivity disorder	0.0149	0.329	CbGeAlD
Methylphenidate—SLC6A2—autonomic nervous system—attention deficit hyperactivity disorder	0.0079	0.175	CbGeAlD
Methylphenidate—SLC6A3—Clearance of dopamine—COMT—attention deficit hyperactivity disorder	0.00554	0.0986	CbGpPWpGaD
Methylphenidate—SLC6A3—Clearance of dopamine—MAOA—attention deficit hyperactivity disorder	0.0055	0.0979	CbGpPWpGaD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—TPH2—attention deficit hyperactivity disorder	0.00425	0.0756	CbGpPWpGaD
Methylphenidate—SLC6A4—Serotonin Transporter Activity—MAOA—attention deficit hyperactivity disorder	0.00256	0.0455	CbGpPWpGaD
Methylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—COMT—attention deficit hyperactivity disorder	0.00253	0.045	CbGpPWpGaD
Methylphenidate—SLC6A3—Neurotransmitter Clearance In The Synaptic Cleft—MAOA—attention deficit hyperactivity disorder	0.00251	0.0447	CbGpPWpGaD
Methylphenidate—SLC6A3—Alpha-synuclein signaling—STUB1—attention deficit hyperactivity disorder	0.00238	0.0424	CbGpPWpGaD
Methylphenidate—SLC6A3—forebrain—attention deficit hyperactivity disorder	0.00228	0.0504	CbGeAlD
Methylphenidate—SLC6A4—forebrain—attention deficit hyperactivity disorder	0.00209	0.0462	CbGeAlD
Methylphenidate—Dexmethylphenidate—SLC6A3—attention deficit hyperactivity disorder	0.00197	0.572	CrCbGaD
Methylphenidate—SLC6A2—forebrain—attention deficit hyperactivity disorder	0.00184	0.0407	CbGeAlD
Methylphenidate—SLC6A4—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00181	0.0322	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00178	0.0316	CbGpPWpGaD
Methylphenidate—SLC6A2—Na+/Cl- dependent neurotransmitter transporters—SLC6A3—attention deficit hyperactivity disorder	0.00168	0.0299	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00155	0.0277	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00153	0.0272	CbGpPWpGaD
Methylphenidate—SLC6A3—midbrain—attention deficit hyperactivity disorder	0.00151	0.0333	CbGeAlD
Methylphenidate—Dexmethylphenidate—SLC6A4—attention deficit hyperactivity disorder	0.00147	0.428	CrCbGaD
Methylphenidate—SLC6A4—midbrain—attention deficit hyperactivity disorder	0.00138	0.0305	CbGeAlD
Methylphenidate—SLC6A3—Monoamine Transport—TPH2—attention deficit hyperactivity disorder	0.00138	0.0245	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—HRH3—attention deficit hyperactivity disorder	0.00135	0.0241	CbGpPWpGaD
Methylphenidate—SLC6A4—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.00129	0.0229	CbGpPWpGaD
Methylphenidate—SLC6A2—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.00124	0.0221	CbGpPWpGaD
Methylphenidate—SLC6A3—nervous system—attention deficit hyperactivity disorder	0.00124	0.0274	CbGeAlD
Methylphenidate—SLC6A3—central nervous system—attention deficit hyperactivity disorder	0.00119	0.0264	CbGeAlD
Methylphenidate—SLC6A2—Amine compound SLC transporters—SLC6A3—attention deficit hyperactivity disorder	0.00117	0.0207	CbGpPWpGaD
Methylphenidate—SLC6A3—cerebellum—attention deficit hyperactivity disorder	0.00117	0.0258	CbGeAlD
Methylphenidate—SLC6A4—nervous system—attention deficit hyperactivity disorder	0.00113	0.0251	CbGeAlD
Methylphenidate—SLC6A2—Monoamine Transport—SLC6A3—attention deficit hyperactivity disorder	0.00111	0.0197	CbGpPWpGaD
Methylphenidate—SLC6A3—Monoamine Transport—SLC6A4—attention deficit hyperactivity disorder	0.0011	0.0196	CbGpPWpGaD
Methylphenidate—SLC6A4—central nervous system—attention deficit hyperactivity disorder	0.00109	0.0242	CbGeAlD
Methylphenidate—CYP2D6—forebrain—attention deficit hyperactivity disorder	0.00101	0.0223	CbGeAlD
Methylphenidate—SLC6A2—nervous system—attention deficit hyperactivity disorder	0.000999	0.0221	CbGeAlD
Methylphenidate—SLC6A4—Synaptic Vesicle Pathway—SNAP25—attention deficit hyperactivity disorder	0.000995	0.0177	CbGpPWpGaD
Methylphenidate—SLC6A2—central nervous system—attention deficit hyperactivity disorder	0.000962	0.0213	CbGeAlD
Methylphenidate—SLC6A3—brain—attention deficit hyperactivity disorder	0.000947	0.0209	CbGeAlD
Methylphenidate—SLC6A4—brain—attention deficit hyperactivity disorder	0.000868	0.0192	CbGeAlD
Methylphenidate—SLC6A2—brain—attention deficit hyperactivity disorder	0.000764	0.0169	CbGeAlD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—GABRQ—attention deficit hyperactivity disorder	0.000621	0.011	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000596	0.0106	CbGpPWpGaD
Methylphenidate—CYP2D6—nervous system—attention deficit hyperactivity disorder	0.000547	0.0121	CbGeAlD
Methylphenidate—SLC6A3—SLC-mediated transmembrane transport—SLC9A9—attention deficit hyperactivity disorder	0.000528	0.00939	CbGpPWpGaD
Methylphenidate—CYP2D6—central nervous system—attention deficit hyperactivity disorder	0.000527	0.0116	CbGeAlD
Methylphenidate—CYP2D6—cerebellum—attention deficit hyperactivity disorder	0.000515	0.0114	CbGeAlD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—TPH2—attention deficit hyperactivity disorder	0.000509	0.00906	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—GABRQ—attention deficit hyperactivity disorder	0.000476	0.00846	CbGpPWpGaD
Methylphenidate—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A3—attention deficit hyperactivity disorder	0.000456	0.00811	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—CHRNA4—attention deficit hyperactivity disorder	0.000438	0.00779	CbGpPWpGaD
Methylphenidate—CYP2D6—Melatonin metabolism and effects—MAOA—attention deficit hyperactivity disorder	0.00042	0.00747	CbGpPWpGaD
Methylphenidate—CYP2D6—brain—attention deficit hyperactivity disorder	0.000418	0.00924	CbGeAlD
Methylphenidate—SLC6A4—Circadian rythm related genes—TPH2—attention deficit hyperactivity disorder	0.000416	0.00739	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—SNAP25—attention deficit hyperactivity disorder	0.000407	0.00724	CbGpPWpGaD
Methylphenidate—SLC6A4—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000382	0.0068	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000369	0.00656	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD1—attention deficit hyperactivity disorder	0.000332	0.00591	CbGpPWpGaD
Methylphenidate—SLC6A2—NRF2 pathway—SLC6A3—attention deficit hyperactivity disorder	0.000329	0.00585	CbGpPWpGaD
Methylphenidate—SLC6A3—NRF2 pathway—SLC6A4—attention deficit hyperactivity disorder	0.000327	0.00582	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD3—attention deficit hyperactivity disorder	0.000322	0.00572	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—CACNB2—attention deficit hyperactivity disorder	0.000318	0.00566	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD4—attention deficit hyperactivity disorder	0.000312	0.00556	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—MAOA—attention deficit hyperactivity disorder	0.000306	0.00545	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000303	0.00538	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—BDNF—attention deficit hyperactivity disorder	0.000295	0.00526	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—DRD2—attention deficit hyperactivity disorder	0.000291	0.00518	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000289	0.00514	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—CHRNA4—attention deficit hyperactivity disorder	0.000273	0.00486	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—SLC9A9—attention deficit hyperactivity disorder	0.000268	0.00477	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmembrane transport of small molecules—GABRQ—attention deficit hyperactivity disorder	0.000256	0.00455	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—SNAP25—attention deficit hyperactivity disorder	0.000254	0.00452	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—HTR2A—attention deficit hyperactivity disorder	0.00025	0.00444	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—CACNB2—attention deficit hyperactivity disorder	0.000244	0.00433	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—CHRNA4—attention deficit hyperactivity disorder	0.000209	0.00373	CbGpPWpGaD
Methylphenidate—SLC6A2—SLC-mediated transmembrane transport—SLC6A3—attention deficit hyperactivity disorder	0.000207	0.00369	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—SNAP25—attention deficit hyperactivity disorder	0.000195	0.00346	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—COMT—attention deficit hyperactivity disorder	0.000193	0.00343	CbGpPWpGaD
Methylphenidate—SLC6A3—Transmission across Chemical Synapses—MAOA—attention deficit hyperactivity disorder	0.000191	0.0034	CbGpPWpGaD
Methylphenidate—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—attention deficit hyperactivity disorder	0.00019	0.00338	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—COMT—attention deficit hyperactivity disorder	0.000148	0.00263	CbGpPWpGaD
Methylphenidate—SLC6A3—Neuronal System—MAOA—attention deficit hyperactivity disorder	0.000147	0.00261	CbGpPWpGaD
Methylphenidate—SLC6A4—SIDS Susceptibility Pathways—EP300—attention deficit hyperactivity disorder	0.000132	0.00235	CbGpPWpGaD
Methylphenidate—SLC6A4—Circadian rythm related genes—EP300—attention deficit hyperactivity disorder	0.000108	0.00192	CbGpPWpGaD
Methylphenidate—SLC6A2—Transmembrane transport of small molecules—SLC6A3—attention deficit hyperactivity disorder	0.000105	0.00187	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—COMT—attention deficit hyperactivity disorder	0.000102	0.00181	CbGpPWpGaD
Methylphenidate—CYP2D6—Biological oxidations—MAOA—attention deficit hyperactivity disorder	0.000101	0.0018	CbGpPWpGaD
Methylphenidate—CYP2D6—Metapathway biotransformation—COMT—attention deficit hyperactivity disorder	0.0001	0.00179	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ADRA2C—attention deficit hyperactivity disorder	4.16e-05	0.00074	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—TPH2—attention deficit hyperactivity disorder	2.87e-05	0.000511	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CACNB2—attention deficit hyperactivity disorder	2.87e-05	0.000511	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—DPYD—attention deficit hyperactivity disorder	2.83e-05	0.000503	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—CACNA1C—attention deficit hyperactivity disorder	2.63e-05	0.000467	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—SNAP25—attention deficit hyperactivity disorder	2.3e-05	0.000409	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—ADRA2A—attention deficit hyperactivity disorder	2.19e-05	0.000389	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—COMT—attention deficit hyperactivity disorder	1.74e-05	0.00031	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—MAOA—attention deficit hyperactivity disorder	1.73e-05	0.000307	CbGpPWpGaD
Methylphenidate—CYP2D6—Metabolism—EP300—attention deficit hyperactivity disorder	7.46e-06	0.000133	CbGpPWpGaD
